-Economic and Political Weekly The compulsory licence for Nexavar is only the beginning of a new battle over drug prices. The grant of a compulsory licence (CL) to Natco Pharma, a relatively small Indian pharmaceutical company, to manufacture and sell the cancer drug sorafenib (Nexavar) has been rightly hailed as a major step forward for public health and the wider availability of life saving medicines.   The German pharmaceutical company Bayer holds the patent...

The government's decision to bust the price as well as monopoly of Bayer's anti-cancer drug, through the process of compulsory licensing now opens up the field for the generic industry to follow suit and could well pave the way for the availability of cheaper drugs for lifestyle diseases.  More generic companies could invoke the compulsory licensing clause of the Indian Patents Act, following Monday's decision to allow Natco Pharma to sell...

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

India's top business and technology schools are struggling to keep pace with the growing gender diversity aspirations of big employers in India Inc.  Women students at IITs have almost doubled to 11% in five years and their numbers at two B-schools - ISB-Hyderabad (29%) and IIM-Kozhikode (36%) - are inching closer to Harvard Business School (39%). Yet, recruiters complain there still aren't enough women graduates to untangle the diversity labyrinth at...

-The Times of India   Bihar chief minister Nitish Kumar today flayed the proposed Seeds Bill, 2011, saying that its provisions were tilted heavily in favour of the multi-national companies and against the interests of the farmers.  "There is no guarantee in the proposed Seeds Bill, 2011, that the seeds produced and marketed by the MNCs will be beneficial to the farmers," Kumar said at a function organized to celebrate the 123rd birth...